MBX Biosciences, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -64 | -60 | -100 | -100 |
EBITDA | -27,265 | -25,735 | -21,568 | -21,744 |
EBIT | -27,329 | -25,795 | -21,618 | -21,805 |
Net Income | -23,517 | -22,062 | -21,618 | -19,411 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -20,645 | -19,094 | -21,935 | -18,141 |
Cash | 45,214 | 75,289 | 223,125 | 39,781 |
Basic Shares | 46,576 | 36,506 | 34,198 | 33,446 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -248 | -244 | -157 | -56 |
EBITDA | -98,055 | -67,950 | -35,154 | -25,705 |
EBIT | -98,303 | -68,194 | -35,311 | -25,761 |
Net Income | -86,971 | -61,922 | -32,563 | -26,135 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -81,878 | -55,555 | -32,107 | -23,563 |
Cash | 75,289 | 49,351 | 30,523 | 24,210 |
Basic Shares | 36,506 | 33,392 | 31,853 | 31,853 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.51 |
2025-12-31 | -$0.49 |
2025-09-30 | -$0.63 |
2025-06-30 | -$0.58 |